title: Rosiglitazone: a case of regulatory hubris.
authors: chairman of cardiovascular medicine, Cleveland Clinic, Cleveland, Ohio.
authors: Steven E
authors: SE
authors: Nissen
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D017277:Drug Approval / Q000458:organization & administration; D004345:Drug Industry; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone